Skip to main content

Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19.

JAMA network open

Authors: Frank L van de Veerdonk, Ilse J E Kouijzer, Aline H de Nooijer, Hans G van der Hoeven, Coen Maas, Mihai G Netea, Roger J M Brüggemann

This case-control study examines the association between receipt of the bradykinin 2 (B2) receptor antagonist icatibant and improved oxygenation in patients with coronavirus disease 2019 (COVID-19).

PMID: 32789513

Participating cluster members